Matthew Lang - Insider Trading & Ownership

Entity
Individual
Location
C/O Myovant Sciences Inc., 2000 Sierra Point Parkway, 9 Th Floor, Brisbane, CA
Summary
The estimated net worth of Matthew Lang is at least $114K dollars as of February 13, 2024. Matthew Lang is the Chief Business Officer of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $114K.
All Insider Reports
All Insider Reports

Ownership of Matthew Lang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LYEL Lyell Immunopharma, Inc. Chief Business Officer $114K Feb 9, 2024
MYOV Myovant Sciences Ltd. General Counsel & Corp. Secy. Mar 10, 2023

Insider Transactions Reported by Matthew Lang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.